Basel Biomed Symposium 2025
On Friday, May 23, 2025, we will celebrate the laying of the foundation stone of the new building for the Department of Biomedicine at the University of Basel. We are using this occasion to launch the Basel Biomed Symposium.
The Basel Biomed Symposium aims to promote scientific networking, cooperation and innovation across the impressive Basel life Science ecosystem. In four sessions, the 1st Basel Biomed Symposium will highlight value chains of biomedical research from basic biology to clinical application.
Draft program, as of February 26, 2025
Friday, May 23, 2025 – Morning 08.45 – 12:00
From Cell Biology to Cell and Tissue Engineering and Therapy
Chairs: Ivan Martin / Prisca Liberali | Speaker: Nina Khanna, University Hospital Basel; Heinz Läubli, University Hospital Basel; Prisca Liberali, FMI/D-BSSE; Matthias Lütolf, IHB/Roche; Ivan Martin, University of Basel, DBM; Sai Reddi, D-BSSE; Botond Roska, IOB; Jürg Steiger, University Hospital Basel; Stefanie Urlinger, Cimeio.
Digital Medicine and AI in Medicine
Chairs: Daniel Müller / Kirsten Taylor | Speaker: Philippe Cattin, University of Basel, DBE; Jens Eckstein, University Hospital Basel; Georg Holländer, BRCCH; Michael Moor, D-BSSE; Daniel Müller, D-BSSE; Kirsten Taylor, Roche; Jürg Utzinger, Swiss TPH; Judith Zaugg, University of Basel, DBM
Afternoon 13:30 – 17:00
From Molecular Pathways to Personalised Medicine and Cancer Therapy
Chairs: Primo Schär / Annette Luther | Speaker: Mohamed Bentires-Alj, University of Basel, DBM; Adrian Britschgi, pRED (tbc) / Roche; Abdullah Kahraman, FHNW; Niklaus Labhardt, University of Basel, DKF; Markus Lill, University of Basel, DPS; Annette Luther, Roche; Falko Schlottig, FHNW; Elisabetta Traggiai, Novartis; Walter Weber, University Hospital Basel
From Neuroscience to Neurology
Chairs: Alex Schier / Michaela Kneissel | Speaker: Silvia Arber, FMI, Biozentrum; Dominique De Quervain, University of Basel DBM, UPK; Urs Frey, UKBB; Christina Granziera, University of Basel DBE, University Hospital Basel; Michaela Kneissel, Novartis; Andreas Papassotiropoulos, University of Basel DBM, UPK; Peter Scheiffele, University of Basel, Biozentrum; Alex Schier, University of Basel, Biozentrum; Derya Shimshek, Novartis.
Researchers from the University of Basel, University Hospital Basel, University Children's Hospital Basel, the D-BSSE of ETH Zurich, the FMI, the IOB, the BRCCH, the FHNW, as well as from Roche and Novartis will contribute to the Biomed Basel Symposium 2025.
Scientific Board of the Basel Biomed Symposium
- Prof. Dr. Primo Schär, Vice President for Research, University of Basel
- Prof. Dr. Alex Schier, Head Department Biozentrum, University of Basel
- Prof. Dr. Ivan Martin, Head Department of Biomedicine, University of Basel
- Prof. Dr. Jürg Steiger, Chief Medical Director, University Hospital
- Prof. Dr. Daniel Müller, Department BSSE, ETH Zürich
- Dr. Annette Luther, Hoffmann-La Roche
- Dr. Michaela Kneissel, Global Head Diseases of Aging and Regenerative Medicine, Novartis
